Hitachi Ventures

Corporate VC Munich, Germany · Founded 2019

Hitachi Ventures invests in pioneering startups at the intersection of technology and biology, focusing on platforms with strong data moats, interdisciplinary teams, and AI-driven approaches to revolutionize patient outcomes and operational efficiency.

About Hitachi Ventures

Hitachi Ventures is the corporate venture arm of Hitachi, with offices in Munich, Tokyo, and Palo Alto, deploying capital into deep tech, climate, industrial, and healthcare companies where there is plausible alignment with Hitachi’s operating divisions including its medical imaging and healthcare IT businesses. The fund operates with relatively long-horizon balance-sheet capital and writes initial checks of roughly $1M to $10M, often participating in Series A through C rounds led by financial investors. Healthcare exposure is one of several verticals rather than the entire mandate, with most healthcare activity skewing to imaging, AI for clinical workflows, surgical robotics, and digital health platforms that can integrate with Hitachi systems. AI focus is genuine across the portfolio and a stated investment theme. Founders best suited are post-product Series A and B CEOs in deep tech or AI-enabled healthcare who would benefit from access to Hitachi’s industrial customer base, R&D resources, and Japanese market entry. Founders who do not fit include pure consumer health, therapeutics-only biotech, and very early-stage teams without a working prototype. Geographic preference is global, with US, Europe, and Japan all in scope. The entry path is warm introduction through a portfolio CEO, a partner at a co-investing financial fund, or a Hitachi business unit executive. LinkedIn outreach to an investor with a clear strategic angle to a Hitachi business is a reasonable secondary option.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Hitachi Ventures

Tools made by companies in Hitachi Ventures's portfolio that we cover in the directory.

CureMD Credentialing
CureMD
Practice Management & Scheduling
CureMD Credentialing is an AI-driven solution that streamlines payer enrollment, reduces administrative costs by up to 80%, and accelerates provider onboarding by up to 90% with a 99.8% accuracy rate.
Concentriq AP-Dx
Proscia
Clinical Decision Support & Reference
Proscia's Concentriq AP-Dx is an FDA-cleared enterprise digital pathology platform for primary diagnosis, designed to accelerate diagnostics and drug development by providing an intuitive experience for viewing, interpreting, sharing, and managing whole slide images.
CureMD AI Medical Billing
CureMD
Medical Billing & RCM
Leverage next-generation AI Medical Billing Software to enhance billing accuracy, reduce denials, and get paid faster.
AI Medical Billing Solution
CureMD
Medical Billing & RCM
CureMD's AI Medical Billing Solution automates and optimizes the revenue cycle for healthcare practices, leveraging artificial intelligence to enhance claims processing, denial management, and overall financial performance.

Portfolio companies in our directory

Other portfolio companies

Companies in Hitachi Ventures's portfolio not currently in our directory.

Team

Stefan Gabriel
CEO & Managing Director
LinkedIn
Wolfgang Seibold
Chief Investment Officer & Partner
LinkedIn
Gayathri Radhakrishnan
Partner
LinkedIn
Pete Bastien
President & Partner
LinkedIn
Tobias Jahn
Partner
LinkedIn
Joanna Soroka
Investment Partner
LinkedIn

Pitch / review this investor

Have you raised from Hitachi Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.